BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8172833)

  • 21. The cost of radiation treatment at an Ontario regional cancer centre.
    Wodinsky HB; Jenkin RD
    CMAJ; 1987 Nov; 137(10):906-9. PubMed ID: 3676933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hospital service utilization by HIV/AIDS patients and their management cost in a provincial genitourinary medicine department.
    Nageswaran A; Kinghorn GR; Shen RN; Priestley CJ; Kyi TT
    Int J STD AIDS; 1995; 6(5):336-44. PubMed ID: 8547414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost Analysis of a Multidisciplinary Vascular Anomaly Clinic.
    Straughan AJ; Mudd PA; Silva AL; Callicott SS; Krakovsky G; Bauman NM
    Ann Otol Rhinol Laryngol; 2019 May; 128(5):401-405. PubMed ID: 30739476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use and cost of HIV service provision in England in 1996. National Prospective Monitoring System (NPMS) Steering Group and NPMS Working Party on Costs.
    Beck EJ; Tolley K; Power A; Mandalia S; Rutter P; Izumi J; Beecham J; Gray A; Barlow D; Easterbrook P; Fisher M; Innes J; Kinghorn G; Mandel B; Pozniak A; Tang A; Tomlinson D; Williams I
    Pharmacoeconomics; 1998 Dec; 14(6):639-52. PubMed ID: 10346416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of production factors, costs, and process efficacy in the radiology department of a local health agency in Italy.
    Mecozzi B; Pancione L; De Intinis G; Gullstrand R; Gualtieri A; Giraudo P
    Radiol Med; 2003 Mar; 105(3):215-29. PubMed ID: 12835645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resource utilisation and cost of ambulatory HIV care in a regional HIV centre in Ireland: a micro-costing study.
    Brennan A; Jackson A; Horgan M; Bergin CJ; Browne JP
    BMC Health Serv Res; 2015 Apr; 15():139. PubMed ID: 25884351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost analysis of palliative care for terminally ill cancer patients in the UK after switching from weak to strong opioids. Palliative Care Advisory Committee.
    Guest JF; Hart WM; Cookson RF
    Pharmacoeconomics; 1998 Sep; 14(3):285-97. PubMed ID: 10186467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evaluation of NIMROD, a community-based service for people with mental handicap: revenue costs.
    Davies L; Felce D; Lowe K; de Paiva S
    Health Serv Manage Res; 1991 Nov; 4(3):170-80. PubMed ID: 10118699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study.
    Wonderling D; McDermott C; Buxton M; Kinmonth AL; Pyke S; Thompson S; Wood D
    BMJ; 1996 May; 312(7041):1269-73. PubMed ID: 8634617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular laboratory cost analysis and the impact of the Resource-Based Relative Value Scale payment system.
    Fillinger MF; Zwolak RM; Musson AM; Cronenwett JL
    J Vasc Surg; 1993 Feb; 17(2):267-78; discussion 278-9. PubMed ID: 8433422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experiences with contracting.
    John C
    Radiogr Today; 1991 Dec; 57(655):23-4. PubMed ID: 1768341
    [No Abstract]   [Full Text] [Related]  

  • 32. Cost of schizophrenia to UK Society. An incidence-based cost-of-illness model for the first 5 years following diagnosis.
    Guest JF; Cookson RF
    Pharmacoeconomics; 1999 Jun; 15(6):597-610. PubMed ID: 10538332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost analysis of a primary health centre in northern India.
    Anand K; Kapoor SK; Pandav CS
    Natl Med J India; 1993; 6(4):160-3. PubMed ID: 8401192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Productivity measurement in radiation oncology.
    Sternick E
    Adm Radiol; 1990 Oct; 9(10):80, 82-3. PubMed ID: 10107649
    [No Abstract]   [Full Text] [Related]  

  • 35. A model for calculating the costs of in vivo dosimetry and portal imaging in radiotherapy departments.
    Kesteloot K; Dutreix A; van der Schueren E
    Radiother Oncol; 1993 Aug; 28(2):108-17. PubMed ID: 8248551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimizing radiologic costs in the DRG environment.
    Henschke CI; Saint-Louis LA; Balter S; Sarkar SD; Balter P; Whalen JP
    Invest Radiol; 1990 Feb; 25(2):194-9. PubMed ID: 2107152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A method of costing anaesthetic practice.
    Broadway PJ; Jones JG
    Anaesthesia; 1995 Jan; 50(1):56-63. PubMed ID: 7702148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre.
    Beck EJ; Mandalia S; Griffith R; Beecham J; Walters MD; Boulton M; Miller DL
    Pharmacoeconomics; 2000 Jan; 17(1):53-69. PubMed ID: 10747765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost of radiotherapy in Sweden.
    Acta Oncol; 1996; 35 Suppl 6():57-71. PubMed ID: 9154086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The costs of hyperfractionation: an economic analysis incorporating consideration of waiting time for treatment.
    Munro AJ
    Clin Oncol (R Coll Radiol); 1995; 7(3):162-7. PubMed ID: 7547518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.